These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2535119)

  • 41. [Phase II study of medroxyprogesterone acetate in advanced breast cancer].
    Ueno K; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nakamura T; Ito Y; Imajo K; Ozeki H
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3198-202. PubMed ID: 2946264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of sex steroids on radioimmunoassayable plasma somatomedin C concentrations.
    Meyer WJ; Furlanetto RW; Walker PA
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1184-7. PubMed ID: 6215421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medroxyprogesterone acetate has opposite effects on the androgen binding protein concentrations in serum and epididymis.
    Lobl TJ; Musto NA; Gunsalus GL; Bardin CW
    Biol Reprod; 1983 Oct; 29(3):697-712. PubMed ID: 6226325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anabolizing and anti-pain effect of the short-term treatment with medroxyprogesterone acetate (MAP) at high oral doses in oncology.
    Pannuti F; Burroni P; Fruet F; Piana E; Strocchi E; Di Marco AR; Cricca A; Camaggi CM
    Panminerva Med; 1980; 22(3):149-56. PubMed ID: 6451859
    [No Abstract]   [Full Text] [Related]  

  • 45. Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis.
    Luciano AA; Turksoy RN; Carleo J
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):323-7. PubMed ID: 2970029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Surprising effect of the treatment with progesterone of desmoid tumors (aggressive fibromatosis)].
    Lanari A
    Medicina (B Aires); 1985; 45(2):105-9. PubMed ID: 2945067
    [No Abstract]   [Full Text] [Related]  

  • 47. The effect of medroxyprogesterone acetate on premature labor in the sheep.
    Tomasi A; Tseng HY; Scommegna A; Burd L
    Am J Obstet Gynecol; 1985 Mar; 151(5):694-700. PubMed ID: 3156503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medroxyprogesterone acetate versus tamoxifen in the therapy of advanced breast cancer.
    Lorenz I; Mechl Z
    Neoplasma; 1985; 32(1):119-24. PubMed ID: 3157070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Uptake of medroxyprogesterone acetate by progestin and androgen target neurons in the brain and pituitary gland of male cynomolgus monkeys.
    Bonsall RW; Rees HD; Michael RP
    Neuroendocrinology; 1990 Dec; 52(6):573-80. PubMed ID: 2149428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase II evaluation of oral medroxyprogesterone acetate in advanced breast cancer: a Northern California Oncology Group Study.
    Tan YO; Hendrickson C; McWhirter K; Kohler M; Hannigan JF; Carlson RW
    Cancer Treat Rep; 1987 Oct; 71(10):969-70. PubMed ID: 2958131
    [No Abstract]   [Full Text] [Related]  

  • 51. [Therapeutic effects of medroxyprogesterone acetate in recurrent or advanced breast cancer].
    Yoshida M; Murai H; Miura S
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):516-23. PubMed ID: 3159345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endogenous serum testosterone in males after different doses and routes of administration of medroxyprogesterone acetate.
    Novak E; Hendrix JW; Seckman CE; Kaiser DG; Stoll RG
    J Reprod Med; 1980 Oct; 25(4):157-60. PubMed ID: 7431362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-dose oral medroxyprogesterone acetate in heavily pretreated patients with metastatic breast cancer.
    Goss PE; Ashley S; Powles TJ; Coombes RC
    Cancer Treat Rep; 1986 Jun; 70(6):777-9. PubMed ID: 2942246
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and validation of a subcritical fluid extraction and high performance liquid chromatography assay for medroxyprogesterone in aquatic products.
    Han Y; Ma Q; Lu J; Xue Y; Xu J; Xue C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 897():90-3. PubMed ID: 22546199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medroxyprogesterone acetate in the treatment of pelvic pain due to venous congestion.
    Reginald PW; Adams J; Franks S; Wadsworth J; Beard RW
    Br J Obstet Gynaecol; 1989 Oct; 96(10):1148-52. PubMed ID: 2531610
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A chemiluminescence enzyme immunoassay (CLEIA) for the determination of medroxyprogesterone acetate in human serum.
    Kim JK; Adam A; Loo JC; Ong H
    J Pharm Biomed Anal; 1995 Jun; 13(7):885-91. PubMed ID: 8562612
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyproterone acetate versus medroxyprogesterone acetate versus diethylstilbestrol in the treatment of prostate cancer: results from EORTC Study 30761.
    Pavone-Macaluso M; Ingargiola GB; de Voogt H; Viggiano G; Barasolo E; Lardennois B; De Pauw M; Sylvester R
    Prog Clin Biol Res; 1987; 243A():379-82. PubMed ID: 2958862
    [No Abstract]   [Full Text] [Related]  

  • 58. The role of pharmacokinetics in the clinical treatment of metastases.
    Pannuti F; Camaggi CM; Strocchi E
    Adv Exp Med Biol; 1988; 233():443-52. PubMed ID: 2975917
    [No Abstract]   [Full Text] [Related]  

  • 59. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment.
    Soufir JC; Jouannet P; Marson J; Soumah A
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):625-32. PubMed ID: 6221496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measurement of medroxyprogesterone acetate (Provera ) by radioimmunoassay.
    Cornette JC; Kirton KT; Duncan GW
    J Clin Endocrinol Metab; 1971 Sep; 33(3):459-66. PubMed ID: 4998975
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.